1 - 17 of 17

Susan J. Back, MD

Susan J. Back

Dr. Back's research focuses on ultrasound and advanced ultrasound applications as well as genitourinary imaging.


L. Charles Bailey, MD, PhD

L. Charles Bailey

Dr. Bailey’s research centers on the development of learning health systems. This endeavor includes the creation of methods to share data across hospitals, recognize the clinical implications of information gathered from different sources, and provide support to clinicians to use this information more effectively.


Frank M. Balis, MD

Frank M. Balis

Dr. Balis's research focuses on the clinical pharmacology of anticancer drugs, new drug development, and clinical trial design and endpoints. He studies the pharmacokinetics and pharmacodynamics of anticancer drugs and has applied pharmacological principles to clinical trial design and clinical drug development. He is developing new biomarkers to serve as surrogate endpoints of drug toxicity or efficacy in clinical trials.


Edward M. Behrens, MD

Edward M. Behrens

Dr. Behrens' research focuses on the pathogenesis and treatment of cytokine storm syndromes, including the hemophagocytic syndromes Hemophagocytic Lymphohistiocytosis (HLH) and Macrophage Activation Syndrome (MAS).


Tami D. Benton, MD

Tami D. Benton

Dr. Benton's research focuses primarily on pediatric mood and anxiety disorders, sickle cell disease and psychiatric conditions, HIV and psychiatric conditions, neuroimmunology and mood disorders, health services research, eating disorders, and ethnically diverse children.


Terri F. Brown-Whitehorn, MD

Terri F. Brown-Whitehorn

Dr. Brown-Whitehorn is an attending physician with the Division of Allergy, the Center for Pediatric Eosinophilic Disorders, and the Integrative Health Program at Children's Hospital of Philadelphia.


Nancy J. Bunin, MD

Dr. Bunin's current research focuses on the development of hematopoietic stem cell graft engineering for allogeneic transplantation to minimize graft-versus-host disease (GVHD), promote engraftment and immune reconstitution. She has also developed protocols for rapid manufacture of viral cytotoxic T lymphocytes to treat or prevent life threatening viral infections post hematopoietic stem cell transplant.